Skip to main content
logo
Beiley Biofund Inc. (TPEX:7882)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.00
+0.20 (0.88%)
At close: Jul 28, 2026

Beiley Biofund Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
1,2271,227140.54139.5
Revenue Growth
482.89%773.27%0.74%-
Gross Profit
1,2271,227140.54139.5
Operating Income
1,1551,15588.8781.92
Net Income
1,1261,12696.5188.62
Earnings Per Share
5.485.480.470.98
EPS Growth
694.24%1065.96%-52.04%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
1,1371,1371,3061,590
Total Debt
5.465.461.062.09
Net Cash (Debt)
1,1321,1321,3051,588
Net Cash Growth
16.62%-13.30%-17.82%-
Net Cash Per Share
5.515.516.3617.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-35.32-35.32217.94-567.9
Capital Expenditures
-0.08-0.08-1.37-1.12
Free Cash Flow
-35.4-35.4216.57-569.02
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
94.11%94.11%63.24%58.73%
Pretax Margin
95.55%95.55%79.43%63.53%
Profit Margin
91.72%91.72%68.67%63.52%
FCF Margin
-2.89%-2.89%154.10%-407.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJul '26 Dec '25 Dec '24 Dec '23
PE Ratio
3.964.99--
PS Ratio
3.634.58--